<VariationArchive VariationID="11097" VariationName="NM_000533.5(PLP1):c.453+28_453+46del" VariationType="Deletion" Accession="VCV000011097" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2017-01-06" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26136" VariationID="11097">
      <GeneList>
        <Gene Symbol="PLP1" FullName="proteolipid protein 1" GeneID="5354" HGNC_ID="HGNC:9086" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103776506" stop="103792619" display_start="103776506" display_stop="103792619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103031438" stop="103047547" display_start="103031438" display_stop="103047547" Strand="+" />
          </Location>
          <OMIM>300401</OMIM>
          <Haploinsufficiency last_evaluated="2021-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PLP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PLP1">Sufficient evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
        <Gene Symbol="RAB9B" FullName="RAB9B, member RAS oncogene family" GeneID="51209" HGNC_ID="HGNC:14090" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103776324" stop="103832257" display_start="103776324" display_stop="103832257" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103077254" stop="103087211" display_start="103077254" display_stop="103087211" Strand="-" />
          </Location>
          <OMIM>300285</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000533.5(PLP1):c.453+28_453+46del</Name>
      <CanonicalSPDI>NC_000023.11:103786751:AATAACAAGGGGTGGGGGAAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103786752" stop="103786770" display_start="103786752" display_stop="103786770" variantLength="19" positionVCF="103786751" referenceAlleleVCF="CAATAACAAGGGGTGGGGGA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103041681" stop="103041699" display_start="103041681" display_stop="103041699" variantLength="19" positionVCF="103041680" referenceAlleleVCF="CAATAACAAGGGGTGGGGGA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.103041683_103041701del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.103041683_103041701del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.103786754_103786772del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.103786754_103786772del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008863.2" sequenceAccession="NG_008863" sequenceVersion="2" change="g.15244_15262del">
            <Expression>NG_008863.2:g.15244_15262del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016452.2" sequenceAccession="NG_016452" sequenceVersion="2" change="g.50513_50531del">
            <Expression>NG_016452.2:g.50513_50531del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128834.3" sequenceAccession="NM_001128834" sequenceVersion="3" change="c.453+28_453+46del">
            <Expression>NM_001128834.3:c.453+28_453+46del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000533.5" sequenceAccession="NM_000533" sequenceVersion="5" change="c.453+28_453+46del" MANESelect="true">
            <Expression>NM_000533.5:c.453+28_453+46del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199478.3" sequenceAccession="NM_199478" sequenceVersion="3" change="c.348+133_348+151del">
            <Expression>NM_199478.3:c.348+133_348+151del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001305004.1" sequenceAccession="NM_001305004" sequenceVersion="1" change="c.288+28_288+46del">
            <Expression>NM_001305004.1:c.288+28_288+46del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300401.0025" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000533.5(PLP1):c.453+28_453+46del AND Pelizaeus-Merzbacher disease, atypical" Accession="RCV000011846" Version="4">
        <ClassifiedConditionList TraitSetID="3070">
          <ClassifiedCondition DB="MedGen" ID="C0751915">Pelizaeus-Merzbacher disease, atypical</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000533.5(PLP1):c.453+28_453+46del AND Pelizaeus-Merzbacher disease" Accession="RCV004589506" Version="1">
        <ClassifiedConditionList TraitSetID="3066">
          <ClassifiedCondition DB="MedGen" ID="C0205711">Pelizaeus-Merzbacher disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-07-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-07-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-01-06" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11071483</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12325077</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12601703</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16287154</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30195799</ID>
        </Citation>
        <DescriptionHistory Dated="2024-07-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3066" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3286" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pelizaeus Merzbacher brain sclerosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 1</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudanophilic leukodystrophy</ElementValue>
                <XRef ID="HP:0003269" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pelizeaus-Merzbacher spectrum disorder</ElementValue>
                <XRef ID="MONDO:0010714" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pelizaeus-Merzbacher disease</ElementValue>
                <XRef ID="Pelizaeus-Merzbacher+disease/5643" DB="Genetic Alliance" />
                <XRef ID="64855000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PMD</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HLD1</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">PLP1-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4265" />
                <XRef ID="4265" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PLP1 disorders of central nervous system myelin formation include a range of phenotypes from Pelizaeus-Merzbacher disease (PMD) to spastic paraplegia 2 (SPG2). PMD typically manifests in infancy or early childhood with nystagmus, hypotonia, and cognitive impairment; the findings progress to severe spasticity and ataxia. Life span is shortened. SPG2 manifests as spastic paraparesis with or without CNS involvement and usually normal life span. Intrafamilial variation of phenotypes can be observed, but the signs are usually fairly consistent within families. Heterozygous females may manifest mild-to-moderate signs of the disease.</Attribute>
                <XRef ID="NBK1182" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301361</ID>
                <ID Source="BookShelf">NBK1182</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="702" DB="Orphanet" />
              <XRef ID="C0205711" DB="MedGen" />
              <XRef ID="MONDO:0010714" DB="MONDO" />
              <XRef Type="MIM" ID="312080" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003269" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3070" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10869" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pelizaeus-Merzbacher disease, atypical</ElementValue>
              </Name>
              <XRef ID="C0751915" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32079" SubmissionDate="2016-12-02" DateLastUpdated="2024-06-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300401.0025_PELIZAEUS-MERZBACHER DISEASE, ATYPICAL" title="PLP1, IVS3, 19-BP DEL, +28_PELIZAEUS-MERZBACHER DISEASE, ATYPICAL" />
        <ClinVarAccession Accession="SCV000032079" DateUpdated="2024-06-02" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a male patient with relatively late onset of nystagmus and rapidly progressive ataxia, Hobson et al. (2000) identified a 19-bp deletion in intron 3 near the splice donor site. The authors suggested that the deletion may define a highly conserved intron enhancer sequence that governs the alternative splicing of PLP and DM20. Three female family members were carriers of the mutation. Hobson et al. (2002) characterized the clinical phenotype of the previously reported male patient who at age 6 years had onset of difficulty in walking, rendering him wheelchair-bound by age 11 years with spastic paraparesis, cerebellar findings, optic atrophy, nystagmus, dysarthria, and cognitive decline. Sequential MRI studies showed delay in myelin formation and diffuse abnormal white matter signals, while MRS studies showed findings consistent with increased turnover of myelin and neuronal and axonal loss. Studies of the deletion in cultured oligodendrocytes showed that it contains a sequence that is critical for efficient PLP-specific splicing. Hobson et al. (2002) concluded that deletion of this region in PLP intron 3 causes a reduction in PLP message and protein, which affects myelin stability and axonal integrity.</Attribute>
              <Citation>
                <ID Source="PubMed">11071483</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12325077</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLP1" />
          </GeneList>
          <Name>PLP1, IVS3, 19-BP DEL, +28</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS3, 19-BP DEL, +28</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300401.0025" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PELIZAEUS-MERZBACHER DISEASE, ATYPICAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9858915" SubmissionDate="2024-07-12" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="NM_000533.5:c.453+28_453+46del" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005077961" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Molecular Diagnostics Lab, Nemours Children's Health, Delaware" OrgID="28338" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16287154</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12325077</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11071483</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12601703</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30195799</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <XRef DB="GTR" ID="GTR000028364.3" URL="http://www.ncbi.nlm.nih.gov/gtr/tests/28364/" />
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">5450</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001257" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000533.5:intron 3</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000533.5:c.453+28_453+46del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="312080" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14599912</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9858915" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001257" MappingRef="HP">
        <MedGen CUI="C0026838" Name="Spasticity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9858915" TraitType="Disease" MappingType="XRef" MappingValue="312080" MappingRef="OMIM">
        <MedGen CUI="C0205711" Name="Pelizaeus-Merzbacher disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="32079" TraitType="Disease" MappingType="Name" MappingValue="PELIZAEUS-MERZBACHER DISEASE, ATYPICAL" MappingRef="Preferred">
        <MedGen CUI="C0751915" Name="Pelizaeus-Merzbacher disease, atypical" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

